Cargando…
Safety and effectiveness of vortioxetine for major depressive disorder: Real-world evidence from a population-based study in South Korea
BACKGROUND: A post-marketing surveillance study was conducted to assess the real-world safety and effectiveness of vortioxetine for the treatment of major depressive disorder (MDD) in South Korea. METHODS: Adult patients aged 19–94 years receiving vortioxetine for MDD at 72 hospitals and clinics in...
Autores principales: | Moon, Seok Woo, Kim, Jee Wook, Kim, Do Hoon, Lee, Kyu Young, Reines, Elin Heldbo, Lee, Minah, Park, Yoo Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018127/ https://www.ncbi.nlm.nih.gov/pubmed/36937717 http://dx.doi.org/10.3389/fpsyt.2023.1075939 |
Ejemplares similares
-
Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study
por: Wang, Gang, et al.
Publicado: (2022) -
The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019) -
Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study
por: Mattingly, Gregory W., et al.
Publicado: (2022) -
Gut Microbiota Changes in Patients With Major Depressive Disorder Treated With Vortioxetine
por: Ye, Xiaolin, et al.
Publicado: (2021) -
Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study
por: Mattingly, Gregory, et al.
Publicado: (2023)